Bronchoscopic Hand Instrument Market Size, Share, & COVID-19 Impact Analysis | Global | 2023-2029 | MedCore

The global market for bronchoscopic hand instruments was valued at $15.3 million in 2022 and is expected to reach $16.3 million by the end of the forecast period, with a CAGR of 1.0%. The report suite on this market exclusively focuses on these instruments and does not cover its extended set.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2029, and Historical Data to 2019

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

GLOBAL BRONCHOSCOPIC HAND INSTRUMENT MARKET INSIGHTS

An emerging trend in this market is the increasing popularity of single-use bronchoscopes. Although they have been present in the market since 2009, their guaranteed sterility feature has only recently caught the attention of healthcare systems worldwide, primarily due to the COVID-19 pandemic. This segment of the market is predicted to experience high growth rates during the forecast period.

GLOBAL BRONCHOSCOPIC HAND INSTRUMENT MARKET SHARE INSIGHTS

The Global bronchoscopic hand instrument market was lead by Karl Storz, LYMOL Medical, and Richard Wolf.

Karl Storz held the top position in the bronchoscopic hand instrument market in 2022, offering a wide range of hand instruments for diverse surgical procedures. To facilitate the use of these instruments with rigid bronchoscopy, Karl Storz often bundles them and provides a central distributor for its clients. This approach has been successful in making Karl Storz one of the prominent players in the bronchoscopic hand instrument market.

MARKET SEGMENTATION SUMMARY

Bronchoscope Hand Instrument Market - MedCore

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela),Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.